Alzamend Neuro, Inc.
ALZN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001677077
In the last 90 days, Alzamend Neuro, Inc. insiders filed 1 open-market purchase and 1 sale; 12 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Alzamend Neuro, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +3 vs. Q3 2021
- Shares held
- 874.3K
- +229.3K (+35.6%) vs. Q3 2021
- Total value
- $1.66M
- −$325.0K (−16.3%) vs. Q3 2021
- New holders
- 13
- 4 more added
- Sold out
- 10
- 2 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $3.26M |
| Q1 2026 | 13 | $723.1K |
| Q4 2025 | 13 | $447.2K |
| Q3 2025 | 11 | $351.3K |
| Q2 2025 | 7 | $6.36K |
| Q1 2025 | 11 | $59.9K |
| Q4 2024 | 17 | $131.7K |
| Q3 2024 | 12 | $71.2K |
| Q2 2024 | 16 | $150.5K |
| Q1 2024 | 13 | $386.8K |
| Q4 2023 | 16 | $334.7K |
| Q3 2023 | 27 | $1.49M |
| Q2 2023 | 24 | $3.13M |
| Q1 2023 | 26 | $2.64M |
| Q4 2022 | 33 | $3.98M |
| Q3 2022 | 17 | $9.41M |
| Q2 2022 | 21 | $2.70M |
| Q1 2022 | 22 | $4.01M |
| Q4 2021 | 20 | $1.66M |
| Q3 2021 | 17 | $1.99M |
| Q2 2021 | 11 | $2.58M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Alzamend Neuro, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Allworth Financial LP | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1,415 | $3.00K | 0.00% | +600+73.6% | Added |
| UBS Group AG | 2,576 | $5.00K | 0.00% | −141−5.2% | Reduced |
| The PNC Financial Services Group, Inc. | 5,000 | $10.0K | 0.00% | +5,000 | New |
| Insight Wealth Strategies, LLC | 10,000 | $19.0K | 0.00% | +10,000 | New |
| Principal Financial Group Inc | 10,400 | $20.0K | 0.00% | +10,400 | New |
| XTX Topco Ltd | 11,134 | $21.0K | 0.01% | +11,134 | New |
| Cutler Group LP | 12,378 | $23.0K | 0.00% | +7,378+147.6% | Added |
| Millennium Management LLC | 13,685 | $26.0K | 0.00% | +13,685 | New |
| Virtu Financial LLC | 23,079 | $44.0K | 0.00% | +23,079 | New |
| Geode Capital Management, LLC | 29,791 | $56.0K | 0.00% | +29,791 | New |
| Two Sigma Securities, LLC | 30,593 | $58.0K | 0.01% | +30,593 | New |
| Jane Street Group, LLC | 39,314 | $75.0K | 0.00% | −15,082−27.7% | Reduced |
| Group One Trading, L.P. | 42,894 | $82.0K | 0.00% | +36,184+539.3% | Added |
| Engineers Gate Manager LP | 43,719 | $83.0K | 0.00% | +43,719 | New |
| Merit Financial Group, LLC | 50,000 | $95.0K | 0.01% | +50,000 | New |
| Simplex Trading, LLC | 65,825 | $125.0K | 0.00% | +65,825 | New |
| Commonwealth Equity Services, LLC | 116,666 | $221.0K | 0.00% | +116,666 | New |
| Marshall Wace, LLP | 163,774 | $313.0K | 0.00% | +163,774 | New |
| Susquehanna International Group, LLP | 201,765 | $383.0K | 0.00% | +109,489+118.7% | Added |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −172,913−100.0% | Sold out |
| Sassicaia Capital Advisers LLC | 0 | $0 | 0.00% | −93,762−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −50,852−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −46,669−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −45,225−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −31,600−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −26,541−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −871−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −326−100.0% | Sold out |